Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| ARUP Laboratories, |
RCV001803646 | SCV002049461 | uncertain significance | Telangiectasia, hereditary hemorrhagic, type 1 | 2021-10-06 | criteria provided, single submitter | clinical testing | The ENG c.67+6_67+14del variant, to our knowledge, is not reported in the medical literature or gene specific databases. This variant is also absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This is an intronic deletion in weakly conserved nucleotides, but computational analyses (Alamut v.2.11) predict that this variant may impact splicing by weakening the nearby canonical donor splice site. Additionally, other variants in this intronic region have been described in affected individuals and are considered pathogenic (Bossler 2006, Giordano 2013, Prigoda 2006). However, given the lack of clinical and functional data, the significance of the variant is uncertain at this time. References: Bossler AD et al. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype. Hum Mutat. 2006 Jul;27(7):667-75. PMID: 16752392. Giordano P et al. Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. J Pediatr. 2013 Jul;163(1):179-86.e1-3. PMID: 23535011. Prigoda NL et al. Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet. 2006 Sep;43(9):722-8. PMID: 16690726. |